BOSTON--(BUSINESS WIRE)--Apr. 3, 2018--
River Associates (NASDAQ: CRAI), a worldwide leader in providing economic,
financial, and management consulting services, today announced that Tiago
Duarte-Silva, in the Finance Practice, Angela
De Martini, Lev
Nicoletti, and Ryan
Tubman, in the Life Sciences Practice, and Oliver
Latham, in the Antitrust & Competition Economics Practice have been
promoted to the role of vice president.
“It is a pleasure to recognize these individuals on their promotions to
vice president,” said CRA’s President and Chief Executive Officer Paul
Maleh. “Their drive and commitment to building their expertise and
being trusted advisors to their clients and colleagues represent the
attributes we seek in leaders of the firm. We are proud of their many
contributions and congratulate them on this career milestone.”
De Martini specializes in pharmaceuticals and medical devices. She
serves clients across a wide range of functions, including business
insights and analytics, marketing, medical affairs, and market access.
She was previously a director at C1 Consulting.
Duarte-Silva specializes in damages and securities disputes. As a
testifying expert, Dr. Duarte-Silva has provided expert opinions and
testified at trial and deposition both in domestic and international
arbitration and litigation as well as before the US Department of
Commerce. He also has several years of industry experience valuing
companies in developed and emerging markets. Dr. Duarte-Silva is an
adjunct professor at Boston College, where he teaches valuation.
Gerlovin has been a key contributor to the growth of the Life
Sciences Practice at CRA over the past 11 years. He has built a
reputation for putting client needs first and collaborating across the
firm to build a strong, multi-disciplinary offering. Lev is seen
internally as a mentor and team-builder and involved in recruiting,
training, and other corporate citizenship initiatives. He co-leads the
practice’s Pharma 2030 thought leadership initiative, focused on the
future direction of the healthcare industry.
Latham has led multiple assignments for CRA. These include on the
economics of platforms, where his work covers high-profile cases,
including running the team and providing expert economic evidence for
Visa Europe in the interchange fee litigation before the High Court,
work related to search and data for NewsCorp and others, and developing
economic evidence for Uber on multiple transactions. Outside of
technology and platforms, he has worked on a number of high-profile
conduct and merger cases.
Nicoletti has expertise in leveraging market research and data
analytics to articulate product and portfolio value and inform clinical
development and commercialization strategy. Dr. Nicoletti focuses on
understanding key value drivers in the context of evolving clinical,
commercial, and payer landscapes, and communicating compelling
narratives across stakeholder groups. Dr. Nicoletti was previously a
director at C1 Consulting and a vice president at Defined Health, where
she led the Immunology and Ophthalmology Practices.
Tubman focuses on leveraging analytics and customer insights to
develop evidence-based strategies for pharmaceutical and biotech
organizations. His work spans early pipeline to in-line products, often
involving patient-level claims, data-based analytics and modelling,
market research, and forecasting. Mr. Tubman was previously a director
at C1 Consulting and held multiple roles at Blue Ridge Partners.
About Charles River Associates (CRA)
Associates® is a global consulting firm specializing in economic,
financial, and management consulting services. CRA advises clients
on economic and financial matters pertaining to litigation and
regulatory proceedings, and guides corporations through critical
business strategy and performance-related issues. Since 1965, clients
have engaged CRA for its unique combination of functional expertise and
industry knowledge, and for its objective solutions to complex problems.
Headquartered in Boston, CRA has offices throughout the world. Detailed
information about Charles River Associates, a registered trade name
of CRA International, Inc., is available at www.crai.com.
Follow us on LinkedIn, Twitter,
View source version on businesswire.com: https://www.businesswire.com/news/home/20180403005802/en/
Source: Charles River Associates
Charles River Associates, 617-425-6453
Merrill Associates, Inc.
Andrew Blazier, 617-542-5300